Haiyun Xie
Sir Run Run Shaw Hospital, 3 Qingchun Road
Hangzhou, 310016, China
Hangzhou, 310016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Correction: N6‑methyladenosine‑modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14‑dependent manner in renal cell carcinoma.
Journal: Molecular cancer
Published: March 03, 2026
ALYREF-mediated m5C modification of CCNA1 drives escape from cell-cycle arrest and contributes to pazopanib resistance in Renal Cell Carcinoma.
Journal: International journal of biological sciences
Published: January 13, 2026
m6Am Methyltransferase PCIF1 Promotes LPP3 Mediated Phosphatidic Acid Metabolism and Renal Cell Carcinoma Progression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 16, 2024
Ligand-dependent CD36 functions in cancer progression, metastasis, immune response, and drug resistance.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 12, 2023
HIF1A-repressed PUS10 regulates NUDC/Cofilin1 dependent renal cell carcinoma migration by promoting the maturation of miR-194-5p.
Journal: Cell & bioscience
Published: February 15, 2023
Biofortification Technology for the Remediation of Cadmium-Contaminated Farmland by the Hyperaccumulator Sedum alfredii under Crop Rotation and Relay Cropping Mode.
Journal: Toxics
Published: October 15, 2022
Exosomes in Genitourinary Cancers: Emerging Mediators of Drug Resistance and Promising Biomarkers.
Journal: International journal of biological sciences
Published: August 24, 2022
Exosome-derived circTFDP2 promotes prostate cancer progression by preventing PARP1 from caspase-3-dependent cleavage.
Journal: Clinical and translational medicine
Published: August 13, 2022
Adding fuel to the fire: The lipid droplet and its associated proteins in cancer progression.
Journal: International journal of biological sciences
Published: May 09, 2022
circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 09, 2022
Last Updated: 09/26/2026